Efficacy and safety of hydroquinone-containing topical regimens versus active topical treatments without hydroquinone for facial melasma: a systematic review of randomized clinical trials published since 2020
This systematic review protocol describes the methods for evaluating the efficacy and safety of hydroquinone-containing topical regimens compared with active topical treatments without hydroquinone in adults with facial melasma. The review will include randomized clinical trials whose first full publication of results appeared from 1 January 2020 to the date of the final search. Hydroquinone monotherapy, hydroquinone-based triple combination therapy, and other hydroquinone-containing combinations will be assessed separately against specific topical comparators. Eligible comparisons will involve exclusively topical treatments, without concomitant procedures or systemic therapies targeting melasma. Searches will be conducted in PubMed, Embase, CENTRAL, Scopus, and LILACS, supplemented by trial registries, reference checking, and citation searching. The primary efficacy outcome will be the change in melasma severity measured using MASI or mMASI, with the scales assessed separately and the primary assessment conducted at the time point closest to 12 weeks within an 8- to 16-week window. Primary safety outcomes will include adverse events and treatment discontinuation due to adverse events. Secondary outcomes will include instrumental pigmentation measurements, clinician and patient assessments, quality of life, and recurrence. Risk of bias will be assessed using the Cochrane RoB 2 tool, and certainty of the evidence will be evaluated using GRADE. Findings will be presented through a structured narrative synthesis without meta-analysis, following the SWiM reporting guideline. The protocol was developed in accordance with PRISMA-P, and the completed review will be reported in accordance with PRISMA 2020.
Authors
- Juan Pablo Holguín-Carvajal (ORCID: https://orcid.org/0000-0002-6844-3962)
- ARIANA ELIZABETH SALCEDO VASQUEZ (ORCID: https://orcid.org/0009-0002-1065-8319)
- PAULA ANABEL GUERRERO VASQUEZ (ORCID: https://orcid.org/0009-0006-3467-4101)
Institutions
- Universidad del Azuay (EC)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-19
- DOI
- https://doi.org/10.5281/zenodo.24381942
- Primary Topic
- Dermatologic Treatments and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00